ENLV
Enlivex Therapeutics Ltd.
$1.11
-$0.04(-3.63%)
38
Overall
--
Value
54
Tech
23
Quality
Market Cap
$26.95M
Volume
276.76K
52W Range
$0.81 - $2.10
Target Price
$10.00
EPS Estimates Overview
| Current Quarter | $-0.12 | Next Quarter | $-0.11 |
| Current Year | $-0.45 | Next Year | $-0.57 |
| QoQ Growth | +8.3% | YoY Growth | -26.7% |
| 3Y EPS CAGR | N/A | Target Price | $10.00 |
| Consensus | Buy | Upside | +802.4% |
Quarterly EPS Estimates
Revenue Analysis
| Current Quarter Rev | N/A | Next Quarter Rev | N/A |
| Revenue Growth | N/A | YoY Growth | N/A |
Estimates are based on analyst consensus and subject to revision. Past performance does not guarantee future results.
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | ENLV | $1.11 | -3.6% | 276.76K |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |
Get Enlivex Therapeutics Ltd. Data in Excel
Stream real-time data directly to your spreadsheets
BUY NOW